The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
2021 · npj Breast Cancer · 257 citations
https://doi.org/10.1038/s41523-021-00346-1
E
Emiel A. M. Janssen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
3.1K
Citations
29
h-index
56
i10-index
Emiel A. M. Janssen is an academic researcher from Griffith University. The author has contributed to research in topics: Breast Cancer Treatment Studies & AI in cancer detection & Cancer Genomics and Diagnostics. The author has an h-index of 29, co-authored 80 publications.
Papers by this author
worksOlaparib monotherapy as primary treatment in unselected triple negative breast cancer
2020 · Annals of Oncology · 210 citations
https://doi.org/10.1016/j.annonc.2020.11.009
Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers
2020 · Scientific Reports · 55 citations
https://doi.org/10.1038/s41598-020-59514-1
Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review
2023 · BMC Cancer · 54 citations
https://doi.org/10.1186/s12885-023-11122-8
Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
2023 · The Journal of Pathology · 46 citations
https://doi.org/10.1002/path.6155
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
2023 · The Journal of Pathology · 45 citations
https://doi.org/10.1002/path.6165
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat